Only in AD Scientific Index !!!!
Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
3 | 209 | 218 | 5,767 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
110 | 67 | 0.609 | 242 | 194 | 0.802 | 54,494 | 23,612 | 0.433 |
4 | 247 | 260 | 6,556 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer | |
106 | 73 | 0.689 | 346 | 251 | 0.725 | 84,388 | 39,409 | 0.467 |
5 | 302 | 316 | 7,951 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Molecular Imaging | Positron emission tomography | Oncology | |
101 | 63 | 0.624 | 473 | 316 | 0.668 | 40,473 | 19,292 | 0.477 |
6 | 338 | 353 | 8,742 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer Immunology | immune killer cells | perforin | granzymes | CAR T cells | |
99 | 51 | 0.515 | 287 | 189 | 0.659 | 36,960 | 11,235 | 0.304 |
8 | 371 | 387 | 9,313 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer | |
97 | 59 | 0.608 | 234 | 171 | 0.731 | 41,323 | 13,775 | 0.333 |
10 | 776 | 820 | 17,131 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
82 | 51 | 0.622 | 334 | 181 | 0.542 | 29,244 | 11,822 | 0.404 |
11 | 792 | 837 | 17,431 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Angiogenesis | lymphangiogenesis | growth factors | receptors | |
82 | 40 | 0.488 | 166 | 93 | 0.560 | 29,895 | 5,818 | 0.195 |
12 | 1,049 | 1,112 | 22,242 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
76 | 45 | 0.592 | 256 | 153 | 0.598 | 29,899 | 11,664 | 0.390 |
15 | 1,368 | 1,458 | 28,608 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Infections in Immunocompromised hosts | |
70 | 53 | 0.757 | 278 | 212 | 0.763 | 21,944 | 13,168 | 0.600 |
18 | 1,726 | 1,853 | 35,893 |
|
Australia | Peter Maccallum Cancer Centre |
Others
prostate cancer genitourinary oncology robotic surgery social media cancer imaging | |
65 | 50 | 0.769 | 250 | 194 | 0.776 | 19,451 | 13,875 | 0.713 |
Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
19 | 1,795 | 1,929 | 36,927 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer | immunotherapy | infection-associated tumors | |
65 | 33 | 0.508 | 207 | 102 | 0.493 | 16,543 | 5,200 | 0.314 |
21 | 1,882 | 2,024 | 38,773 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
64 | 32 | 0.500 | 122 | 82 | 0.672 | 16,250 | 5,017 | 0.309 |
23 | 2,054 | 2,214 | 41,856 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Breast | |
62 | 41 | 0.661 | 152 | 111 | 0.730 | 17,386 | 9,907 | 0.570 |
24 | 2,119 | 2,287 | 43,366 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Drug Development | Phase I Trials | Sarcoma | Colorectal Cancer | |
61 | 48 | 0.787 | 180 | 140 | 0.778 | 27,286 | 16,591 | 0.608 |
29 | 2,605 | 2,816 | 52,771 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
57 | 44 | 0.772 | 162 | 128 | 0.790 | 18,109 | 12,137 | 0.670 |
31 | 2,748 | 2,975 | 55,470 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Breast Cancer | Clinical Trials | |
56 | 43 | 0.768 | 114 | 81 | 0.711 | 19,890 | 12,130 | 0.610 |
32 | 2,910 | 3,156 | 58,672 |
|
Australia | Peter Maccallum Cancer Centre |
Others
GI oncology / survivorship / supportive care | |
55 | 39 | 0.709 | 151 | 104 | 0.689 | 10,123 | 4,691 | 0.463 |
35 | 3,908 | 4,278 | 79,001 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Exercise Oncology | |
49 | 41 | 0.837 | 84 | 79 | 0.940 | 13,085 | 6,707 | 0.513 |
36 | 3,920 | 4,291 | 79,231 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
49 | 39 | 0.796 | 119 | 99 | 0.832 | 12,674 | 9,907 | 0.782 |
37 | 4,257 | 4,664 | 85,903 |
|
Australia | Peter Maccallum Cancer Centre |
Others
lymphoma | |
48 | 27 | 0.563 | 109 | 58 | 0.532 | 9,294 | 3,269 | 0.352 |
38 | 4,435 | 4,880 | 89,835 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
47 | 30 | 0.638 | 73 | 55 | 0.753 | 9,622 | 4,573 | 0.475 |
41 | 5,093 | 5,619 | 103,866 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Infections in the immunocompromised host | Healthcare-associated infections | |
44 | 32 | 0.727 | 122 | 98 | 0.803 | 5,935 | 3,384 | 0.570 |
43 | 5,553 | 6,145 | 113,843 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer Immunotherapy | CAR T cells | adenosine | |
42 | 39 | 0.929 | 51 | 49 | 0.961 | 10,094 | 8,240 | 0.816 |
45 | 6,166 | 6,838 | 126,366 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
41 | 14 | 0.341 | 96 | 25 | 0.260 | 6,908 | 900 | 0.130 |
49 | 6,595 | 7,310 | 135,755 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
39 | 31 | 0.795 | 80 | 70 | 0.875 | 6,300 | 2,989 | 0.474 |
50 | 7,826 | 8,725 | 161,604 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
36 | 28 | 0.778 | 64 | 43 | 0.672 | 4,989 | 2,287 | 0.458 |
52 | 8,054 | 8,991 | 166,751 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
36 | 19 | 0.528 | 52 | 31 | 0.596 | 7,362 | 1,383 | 0.188 |
53 | 8,120 | 9,065 | 168,498 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Breast Cancer | |
35 | 33 | 0.943 | 56 | 52 | 0.929 | 9,341 | 7,967 | 0.853 |
55 | 8,337 | 9,302 | 172,197 |
|
Australia | Peter Maccallum Cancer Centre |
Others
cancer sex-disparity | TP53 | cancer | X chromosome | sex chromosomes | |
35 | 26 | 0.743 | 58 | 47 | 0.810 | 4,412 | 2,555 | 0.579 |
57 | 8,631 | 9,646 | 179,764 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer | Immunology | Melanoma | Surgery | |
34 | 29 | 0.853 | 81 | 74 | 0.914 | 8,791 | 6,482 | 0.737 |
A New and Different Feature!!!! University Subject Rankings in 12 subjects:Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc. |
||||||||||||||||
60 | 9,117 | 10,202 | 191,212 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Tumour biology | |
33 | 28 | 0.848 | 45 | 41 | 0.911 | 17,935 | 8,652 | 0.482 |
61 | 9,857 | 11,038 | 206,744 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Tumour Immunology | |
32 | 23 | 0.719 | 45 | 33 | 0.733 | 7,811 | 2,423 | 0.310 |
69 | 11,228 | 12,636 | 240,730 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
29 | 28 | 0.966 | 44 | 41 | 0.932 | 9,775 | 8,627 | 0.883 |
72 | 11,911 | 13,415 | 256,878 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Infections in the immunocompromised host | |
28 | 26 | 0.929 | 50 | 46 | 0.920 | 2,757 | 2,284 | 0.828 |
77 | 13,971 | 15,800 | 310,286 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Molecular immunology | |
25 | 24 | 0.960 | 30 | 28 | 0.933 | 2,640 | 2,054 | 0.778 |
78 | 14,108 | 15,949 | 313,459 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer immunotherapy | |
25 | 22 | 0.880 | 33 | 29 | 0.879 | 3,379 | 2,326 | 0.688 |
80 | 14,727 | 16,669 | 331,333 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
24 | 23 | 0.958 | 29 | 29 | 1.000 | 1,855 | 1,322 | 0.713 |
81 | 14,914 | 16,878 | 336,012 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
24 | 20 | 0.833 | 46 | 40 | 0.870 | 2,101 | 1,724 | 0.821 |
91 | 17,792 | 20,217 | 415,036 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
21 | 17 | 0.810 | 28 | 25 | 0.893 | 1,442 | 714 | 0.495 |
92 | 18,285 | 20,794 | 431,075 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Breast Oncology | |
20 | 20 | 1.000 | 27 | 27 | 1.000 | 4,276 | 3,963 | 0.927 |
Only in AD Scientific Index !!!!Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities |
||||||||||||||||
94 | 19,008 | 21,633 | 449,494 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
20 | 15 | 0.750 | 24 | 19 | 0.792 | 3,898 | 2,773 | 0.711 |
95 | 19,394 | 22,090 | 462,217 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer | Immunology | Cancer Immunotherapy | |
19 | 19 | 1.000 | 24 | 24 | 1.000 | 1,766 | 1,703 | 0.964 |
97 | 19,891 | 22,643 | 474,660 |
|
Australia | Peter Maccallum Cancer Centre |
Others
senescence | high throughput screening | cancer | ovarian | breast | |
19 | 16 | 0.842 | 23 | 21 | 0.913 | 2,211 | 1,201 | 0.543 |
98 | 19,946 | 22,706 | 476,444 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Models of Cancer Translational Research Centre | |
19 | 15 | 0.789 | 32 | 24 | 0.750 | 1,178 | 747 | 0.634 |
99 | 20,553 | 23,426 | 496,487 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
18 | 18 | 1.000 | 19 | 19 | 1.000 | 1,905 | 1,779 | 0.934 |
101 | 21,912 | 25,012 | 539,462 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
17 | 15 | 0.882 | 28 | 20 | 0.714 | 2,603 | 1,827 | 0.702 |
103 | 22,401 | 25,587 | 554,859 |
|
Australia | Peter Maccallum Cancer Centre |
Others
MHC class I | antigen presentation | cancer biology | cancer immunology | |
17 | 13 | 0.765 | 18 | 15 | 0.833 | 2,911 | 2,383 | 0.819 |
107 | 23,008 | 26,304 | 577,832 |
|
Australia | Peter Maccallum Cancer Centre |
Others
|
16 | 15 | 0.938 | 18 | 17 | 0.944 | 2,999 | 2,269 | 0.757 |
109 | 23,177 | 26,498 | 582,802 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Cancer-related fatigue | implementation | occupational therapy | |
16 | 14 | 0.875 | 21 | 17 | 0.810 | 802 | 646 | 0.805 |
110 | 23,463 | 26,817 | 591,086 |
|
Australia | Peter Maccallum Cancer Centre |
Others
Drosophila | |
16 | 13 | 0.813 | 18 | 14 | 0.778 | 1,359 | 625 | 0.460 |